• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低级别胶质瘤中具有m6A修饰特征的新型三个枢纽长链非编码RNA的鉴定与验证

Identification and Validation of a Novel Three Hub Long Noncoding RNAs With m6A Modification Signature in Low-Grade Gliomas.

作者信息

Nguyen Quang-Huy, Nguyen Tin, Le Duc-Hau

机构信息

School of Computer Science and Engineering, Thuyloi University, Hanoi, Vietnam.

Department of Computer Science and Engineering, University of Nevada, Reno, NV, United States.

出版信息

Front Mol Biosci. 2022 Feb 14;9:801931. doi: 10.3389/fmolb.2022.801931. eCollection 2022.

DOI:10.3389/fmolb.2022.801931
PMID:35237657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8882983/
Abstract

It has been evident that N6-methyladenosine (m6A)-modified long noncoding RNAs (m6A-lncRNAs) involves regulating tumorigenesis, invasion, and metastasis for various cancer types. In this study, we sought to pick computationally up a set of 13 hub m6A-lncRNAs in light of three state-of-the-art tools WGCNA, iWGCNA, and oCEM, and interrogated their prognostic values in brain low-grade gliomas (LGG). Of the 13 hub m6A-lncRNAs, we further detected three hub m6A-lncRNAs as independent prognostic risk factors, including and . Then, the m6ALncSig model was built based on these three hub m6A-lncRNAs. Patients with LGG next were divided into two groups, high- and low-risk, based on the median m6ALncSig score. As predicted, the high-risk group was more significantly related to mortality. The prognostic signature of m6ALncSig was validated using internal and external cohorts. In summary, our work introduces a high-confidence prognostic prediction signature and paves the way for using m6A-lncRNAs in the signature as new targets for treatment of LGG.

摘要

很明显,N6-甲基腺苷(m6A)修饰的长链非编码RNA(m6A-lncRNAs)参与调控多种癌症类型的肿瘤发生、侵袭和转移。在本研究中,我们试图根据三种先进工具WGCNA、iWGCNA和oCEM,通过计算筛选出一组13个枢纽m6A-lncRNAs,并研究它们在脑低级别胶质瘤(LGG)中的预后价值。在这13个枢纽m6A-lncRNAs中,我们进一步检测到三个枢纽m6A-lncRNAs作为独立的预后危险因素,包括 和 。然后,基于这三个枢纽m6A-lncRNAs构建了m6ALncSig模型。接下来,根据m6ALncSig评分中位数,将LGG患者分为高风险和低风险两组。正如预测的那样,高风险组与死亡率的相关性更显著。使用内部和外部队列验证了m6ALncSig的预后特征。总之,我们的工作引入了一个高可信度的预后预测特征,并为将特征中的m6A-lncRNAs用作LGG治疗的新靶点铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b8/8882983/a06af1210f01/fmolb-09-801931-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b8/8882983/87c6111432fb/fmolb-09-801931-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b8/8882983/19de8c172d7a/fmolb-09-801931-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b8/8882983/a06af1210f01/fmolb-09-801931-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b8/8882983/87c6111432fb/fmolb-09-801931-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b8/8882983/19de8c172d7a/fmolb-09-801931-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b8/8882983/a06af1210f01/fmolb-09-801931-g003.jpg

相似文献

1
Identification and Validation of a Novel Three Hub Long Noncoding RNAs With m6A Modification Signature in Low-Grade Gliomas.低级别胶质瘤中具有m6A修饰特征的新型三个枢纽长链非编码RNA的鉴定与验证
Front Mol Biosci. 2022 Feb 14;9:801931. doi: 10.3389/fmolb.2022.801931. eCollection 2022.
2
Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma.具有m6A修饰的Hub长链非编码RNA在肾透明细胞癌中的特征及预后价值
Front Mol Biosci. 2021 Jul 6;8:682471. doi: 10.3389/fmolb.2021.682471. eCollection 2021.
3
The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma.m6A/m5C 相关长非编码 RNA 标志物在低级别胶质瘤中的预后价值及免疫图谱
BMC Bioinformatics. 2023 Jul 4;24(1):274. doi: 10.1186/s12859-023-05386-x.
4
m6A-related lncRNAs are potential biomarkers for the prognosis of COAD patients.与m6A相关的长链非编码RNA是结肠癌患者预后的潜在生物标志物。
Front Oncol. 2022 Aug 30;12:920023. doi: 10.3389/fonc.2022.920023. eCollection 2022.
5
Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.鉴定和验证一种新型的八个突变衍生的长非编码 RNA 特征作为低级别胶质瘤基因组不稳定性的预后生物标志物。
Aging (Albany NY). 2021 Jun 3;13(11):15164-15192. doi: 10.18632/aging.203079.
6
N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.N6-甲基腺苷相关长非编码 RNA 特征可预测结直肠癌患者的总生存期。
Genes (Basel). 2021 Aug 31;12(9):1375. doi: 10.3390/genes12091375.
7
Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.N6-甲基腺苷相关长非编码 RNA 预后signature、免疫检查点和免疫细胞浸润的综合分析在透明细胞肾细胞癌中的研究。
Immun Inflamm Dis. 2021 Dec;9(4):1596-1612. doi: 10.1002/iid3.513. Epub 2021 Aug 25.
8
Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma.鉴定N6-甲基腺苷相关长链非编码RNA作为胶质瘤的预后标志物
Front Oncol. 2022 Mar 3;12:789283. doi: 10.3389/fonc.2022.789283. eCollection 2022.
9
Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.开发并验证一种新型的 N6-甲基腺苷(m6A)相关多长非编码 RNA(lncRNA)在胰腺腺癌中的预后标志物。
Bioengineered. 2021 Dec;12(1):2432-2448. doi: 10.1080/21655979.2021.1933868.
10
A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer.一个包含十个 N6-甲基腺苷相关的长非编码 RNA 的签名可以预测三阴性乳腺癌的预后。
J Clin Lab Anal. 2021 Jun;35(6):e23779. doi: 10.1002/jcla.23779. Epub 2021 May 2.

引用本文的文献

1
LncRNA FLG-AS1 inhibits esophageal squamous cell carcinoma by regulating the miR-23a-3p/HOXD10 axis.长链非编码RNA FLG-AS1通过调控miR-23a-3p/HOXD10轴抑制食管鳞状细胞癌。
Hereditas. 2025 Jun 3;162(1):96. doi: 10.1186/s41065-025-00461-0.
2
The Comprehensive Analysis of m6A-Associated Anoikis Genes in Low-Grade Gliomas.低级别胶质瘤中m6A相关失巢凋亡基因的综合分析
Brain Sci. 2023 Sep 12;13(9):1311. doi: 10.3390/brainsci13091311.
3
Construction and Validation of a Novel Prognostic Signature of Idiopathic Pulmonary Fibrosis by Identifying Subtypes Based on Genes Related to 7-Methylguanosine Modification.

本文引用的文献

1
oCEM: Automatic detection and analysis of overlapping co-expressed gene modules.OCEM:重叠共表达基因模块的自动检测和分析。
BMC Genomics. 2022 Jan 8;23(1):39. doi: 10.1186/s12864-021-08072-5.
2
Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine.长链非编码 RNA NEAT1 通过 N6-甲基腺苷促进前列腺癌骨转移。
Mol Cancer. 2020 Dec 12;19(1):171. doi: 10.1186/s12943-020-01293-4.
3
Improving existing analysis pipeline to identify and analyze cancer driver genes using multi-omics data.
通过基于与7-甲基鸟苷修饰相关基因识别亚型构建和验证特发性肺纤维化的新型预后标志物
Front Genet. 2022 Jun 9;13:890530. doi: 10.3389/fgene.2022.890530. eCollection 2022.
改进现有的分析流程,利用多组学数据识别和分析癌症驱动基因。
Sci Rep. 2020 Nov 25;10(1):20521. doi: 10.1038/s41598-020-77318-1.
4
RMVar: an updated database of functional variants involved in RNA modifications.RMVar:一个更新的数据库,包含涉及 RNA 修饰的功能变体。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1405-D1412. doi: 10.1093/nar/gkaa811.
5
The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature.IDH 突变型低级别胶质瘤和胶质母细胞瘤中 CDKN2A 纯合缺失的预后意义:当代文献的系统评价。
J Neurooncol. 2020 Jun;148(2):221-229. doi: 10.1007/s11060-020-03528-2. Epub 2020 May 8.
6
N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1.N6-甲基腺苷诱导的 miR-143-3p 通过调节 VASH1 促进肺癌的脑转移。
Mol Cancer. 2019 Dec 10;18(1):181. doi: 10.1186/s12943-019-1108-x.
7
Multiomics analysis on DNA methylation and the expression of both messenger RNA and microRNA in lung adenocarcinoma.肺腺癌中 DNA 甲基化和信使 RNA 及 microRNA 表达的多组学分析。
J Cell Physiol. 2019 May;234(5):7579-7586. doi: 10.1002/jcp.27520. Epub 2018 Oct 28.
8
A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas.一种基于放射组学特征的无创预测模型,用于预测低级别胶质瘤患者的无进展生存期。
Neuroimage Clin. 2018;20:1070-1077. doi: 10.1016/j.nicl.2018.10.014. Epub 2018 Oct 16.
9
Long noncoding RNAs in cancer cells.癌细胞中的长非编码 RNA
Cancer Lett. 2018 Apr 10;419:152-166. doi: 10.1016/j.canlet.2018.01.053.
10
Long noncoding RNAs and cancer, an overview.长链非编码RNA与癌症:综述
Steroids. 2018 May;133:93-95. doi: 10.1016/j.steroids.2017.12.012. Epub 2018 Jan 6.